Company Overview and News
Number forecast operators (NFOs) Maintain hold: Finance Minister Lim Guan Eng has stated that the government plans to reduce the number of special draws for all number forecast operators (NFOs) beginning 2019. The quantum of reduction was not revealed, although he said the new policy would be announced in Budget 2019 on Nov 2.
“We estimate that every one less special draw will trim our estimates on Berjaya Sports’ and Magnum’s earnings per share (EPS) by only 0.3%,” Maybank IB Research said.
KUALA LUMPUR (Aug 1): Berjaya Sports Toto Bhd (BToto) has appointed Tan Sri Tan Kok Ping as non-independent and non-executive chairman of the group effective immediately, replacing Cheah Tek Kuang who has resigned.
1562 4219 BSMAF 7087 1818
THE FIFA World Cup season is here. For sports fans, it will be a period of fun and excitement, while for some businesses, such as those operating in the consumer sector, it will be a period of business boom.
Berjaya Sports Toto Bhd (June 19, RM2.49) Maintain hold with a higher target price (TP) of RM2.30: Stripping off exceptional items which consist of impairments for certain available-for-sale investments (RM16 million), and goodwill relating to its Philippine subsidiary, Philippine Gaming Management Corp (PGMC) totalling RM11 million, BToto reported a core net profit of RM62 million (-11% year-on-year [y-o-y], +5% quarter-on-quarter [q-o-q]) in the fourth quarter of its financial year ended April 30, 2018 (4QFY18).
KUALA LUMPUR (June 19): Shares in Berjaya Sports Toto Bhd (BToto) fell as much as eight sen or 3.2% to RM2.45 within the first hour of trading today, tracking the company's fourth quarter results released post market hours on Monday (June 18).
KUALA LUMPUR (June 19): PublicInvest Research has downgraded Berjaya Sports Toto Bhd (Btoto) to “Neutral” at RM2.53 with a lower target price of RM2.62 (from RM2.98) after Btoto reported a 51.5% decline in 4QFY18 net profit to RM35.2 million while FY18 net profit was flattish at RM230.5 million.
KUALA LUMPUR (June 18): Based on corporate announcements and news flow today, companies in focus on Monday (June 19) may include: Y&G Corp Bhd, XingHe Holdings Bhd, Malaysia Pacific Corporation Bhd, Berjaya Sports Toto Bhd, Priceworth International Bhd and Cahya Mata Sarawak Bhd.
2852 1562 0095 7123
KUALA LUMPUR (June 18): Number forecast operator (NFO) Berjaya Sports Toto Bhd’s (BToto) net profit more than halved to RM35.18 million in the fourth quarter ended April 30, 2018 (4QFY18), from RM72.49 million a year ago, due to impairment in value of available-for-sales quoted investments and goodwill on leasing of lottery equipment business in the Philippines.
1562 BSMAF 1818
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...